Lung Cancer Screening Registry and Quality Improvement Act of 2021.
Bill: H.R.107 | Sponsor: Rep. Higgins, Brian (D-NY)
Policy area: Health

Summary:
Lung Cancer Screening Registry and Quality Improvement Act of 2021
This bill establishes several grant programs and requirements for registries that collect data from lung cancer screenings with low-dose computed tomography (LDCT) under Medicare. (Currently, for purposes of Medicare coverage, radiology imaging facilities that furnish such LDCT screenings must report certain data to approved registries.)
Specifically, the bill provides funds for FY2022-FY2026 for grants to help entities establish free registries, and requires registries to be interoperable in order to receive federal funds. The bill also provides grants to support the development of related quality measures for lung cancer screenings.

To provide funds to the Centers for Medicare & Medicaid Services to 
     provide grants to entities to establish lung cancer screening 
registries approved by the Centers for Medicare & Medicaid Services for 
    submission of certain data required for reimbursement under the 
    Medicare program for certain screening services, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Lung Cancer Screening Registry and 
Quality Improvement Act of 2021.''

SEC. 2. GRANTS TO ESTABLISH LUNG CANCER SCREENING REGISTRIES APPROVED 
              BY THE CENTERS FOR MEDICARE & MEDICAID SERVICES FOR 
              SUBMISSION OF CERTAIN DATA REQUIRED FOR REIMBURSEMENT 
              UNDER THE MEDICARE PROGRAM FOR CERTAIN SCREENING 
              SERVICES.

    (a) Grants.--There is appropriated to the Centers for Medicare & 
Medicaid Services, out of any moneys in the Treasury not otherwise 
appropriated, $2,000,000 for each of fiscal years 2022 through 2026 to 
make grants to entities to establish and carry out registries that are 
approved by the Centers for Medicare & Medicaid Services as meeting the 
requirements described in the Final National Coverage Determination on 
Screening for Lung Cancer with Low Dose Computed Tomography published 
on February 5, 2015.
    (b) Limitation.--As a condition of receiving a grant pursuant to 
subsection (a), with respect to a registry described in such 
subsection, an entity may not charge any fee for access to such 
registry.

SEC. 3. ENCOURAGING DATA INTEROPERABILITY AMONG LUNG CANCER SCREENING 
              REGISTRIES.

    The Secretary of Health and Human Services shall take such actions 
as may be necessary to ensure data interoperability between all 
registries described in section 1(a) (including such registries 
established using funds provided under such section, interoperability 
between all CMS-approved lung cancer screening registries), including 
by--
            (1) requiring interoperability as a condition of receiving 
        any Federal funding for such a registry; and
            (2) revoking any such funding for such a registry if the 
        registry is not interoperable with other such registries.

SEC. 4. GRANTS FOR THE DEVELOPMENT OF LUNG CANCER SCREENING, DETECTION, 
              AND PREVENTION QUALITY MEASURES.

    (a) In General.--Subject to subsection (c), the Secretary of Health 
and Human Services shall award competitive grants to organizations with 
quality measure development expertise to develop, using data contained 
in registries described in section 1(a) (including such a registry 
established using funds provided under such section), quality and 
efficiency measures described in subsection (b) for review and 
potential endorsement by a consensus-based entity with a contract in 
effect under section 1890 of the Social Security Act (42 U.S.C. 
1395aaa) for uses including as described in subsection (b)(7)(B) of 
such section.
    (b) Quality and Efficiency Measures Described.--For purposes of 
subsection (a), quality and efficiency measures described in this 
subsection are quality and efficiency measures to improve health care 
efficiency and outcomes with respect to lung cancer screening 
practices, early detection of lung cancer, and lung cancer prevention.
    (c) Authorization of Appropriations.--There is authorized to be 
appropriated to carry out subsection (a) $1,000,000 for each of fiscal 
years 2022 through 2026.
                                 <all>